Is CDX.AX stock a buy after the recent drop?

CDX.AX stock shows an oversold bounce setup, but fundamental weakness remains. Short-term traders may buy on a volume-backed move above A$0.060. Longer-term investors should wait for improving EPS or contract visibility before buying.

What is Meyka AI's price forecast for CDX.AX stock?

Meyka AI's forecast model projects **A$0.02288** over 12 months, implying **-36.46%** from the current **A$0.036**. Forecasts are model-based projections and not guarantees.

Which levels matter for a CDX.AX stock trade?

Key levels: support near **A$0.030** and **A$0.020**, resistance at **A$0.060** and **A$0.080**. Volume near the average **458,209.00** confirms any sustainable bounce.

Where can I read CDX.AX stock news and filings?

Official company releases are on CardieX’s website and financial coverage appears on outlets such as Investing.com. Track both for regulatory updates and contract announcements.

AU Stocks

A$0.036 CDX.AX CardieX Limited ASX 28 Jan 2026: Oversold bounce, watch A$0.06

ByHuzaifa Zahoor January 28, 2026

CDX.AX stock closed at A$0.036 on 28 Jan 2026 after a shallow intraday range (Day Low A$0.035, Day High A$0.038). CardieX Limited (CDX.AX) has fallen 63.64% YTD and trades well below its 200-day average of A$0.06546, setting up an oversold bounce opportunity if buying volume returns. We examine price drivers, cash metrics, and technical triggers that could deliver a short-term rebound while highlighting why fundamental weakness keeps longer-term risk elevated.